Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease
Status:
Terminated
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of Talaporfin Sodium
(LS11) Photodynamic Therapy in patients with late stage Age-Related Macular Disease (AMD).